Excessive Daytime Sleepiness



Pitolisant (BF2.649) in the Treatment of Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnoea Syndrome, Treated or Not by Nasal Continuous Positive Airway Pressure, But Still Complaining of Excessive Daytime Sleepiness


Conditions:   Excessive Daytime Sleepiness;   Obstructive Sleep Apnea
Interventions:   Drug: Pitolisant (BF2.649);   Drug: Placebo Oral Tablet
Sponsor:   Bioprojet
Not yet recruiting - verified November 2016


Bright Light Therapy for Non-motor Symptoms in Parkinson's Disease


Condition:   Parkinson's Disease
Intervention:   Device: Light Therapy Device
Sponsor:   Massachusetts General Hospital
Not yet recruiting - verified September 2016


The Effect of Caffeine on the Narcoleptic Patients


Condition:   Narcolepsy
Interventions:   Drug: Vivarin;   Drug: Fiber
Sponsors:   King Saud University;   King Saud Medical City
Recruiting - verified October 2016


Pitolisant (BF2.649) in the Treatment of EDS in Patients With OSA


Conditions:   Excessive Daytime Sleepiness;   Obstructive Sleep Apnea
Interventions:   Drug: Pitolisant (BF2.649);   Drug: Placebo
Sponsor:   Bioprojet
Completed - verified November 2016


Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy


Conditions:   Excessive Daytime Sleepiness;   Cataplexy;   Narcolepsy
Interventions:   Drug: Sodium Oxybate;   Drug: Placebo
Sponsor:   Flamel Ireland Limited
Recruiting - verified May 2017


Efficacy of Oral Appliance for Upper Airway Resistance Syndrome


Condition:   Upper Airway Resistance Syndrome
Interventions:   Device: Brazilian Dental Appliance;   Other: Placebo
Sponsor:   Associação Fundo de Incentivo à Pesquisa
Recruiting - verified July 2016


Varenicline Treatment for Excessive Daytime Sleepiness in Parkinson's Disease


Condition:   Parkinson's Disease
Interventions:   Drug: Varenicline;   Drug: Placebo (for varenicline)
Sponsors:   VU University Medical Center;   Centre for Human Drug Research, Netherlands
Active, not recruiting - verified December 2016


CPAP to Reduce Arterial Stiffness in Non Sleepy, Moderate to Severe Obstructive Sleep Apnea (STIFFSLEEP)


Conditions:   Obstructive Sleep Apnea;   Vascular Stiffness;   Sleep Disorder Daytime Somnolence
Intervention:   Device: CPAP (ResMed S9 AutoSet)
Sponsors:   Centro Hospitalar de Lisboa Central;   Universidade Nova de Lisboa
Active, not recruiting - verified July 2016


Sleep Quality, Daytime Sleepiness and Insomnia in Patients With Endometriosis: a Case-control Study.


Conditions:   Endometriosis;   Sleep
Interventions:   Other: Pittsburgh Sleep Quality Index.;   Other: Epworth sleepiness scale.;   Other: Insomnia Severity Index.;   Other: The Endometriosis Health Profile.
Sponsor:   IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Completed - verified May 2017


Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP)


Conditions:   Narcolepsy With Cataplexy;   Excessive Daytime Sleepiness
Interventions:   Drug: Pitolisant;   Drug: Placebo
Sponsor:   Bioprojet
Completed - verified July 2015


Circadian Rhythms and Sleep-Wake Cycles in Parkinson's Disease


Condition:   Parkinson's Disease
Intervention:   Other: Light exposure
Sponsors:   Massachusetts General Hospital;   National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified March 2017


Treatment of Post-Traumatic Brain Injury (Post-TBI) Fatigue With Light Therapy


Conditions:   Traumatic Brain Injury;   Fatigue
Interventions:   Device: Bright White Light (BWL);   Device: Dim Red Light (DRL)
Sponsor:   Icahn School of Medicine at Mount Sinai
Recruiting - verified March 2017


Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.


Condition:   Treatment of Excessive Daytime Sleepiness in Narcolepsy
Interventions:   Drug: BF2.649;   Drug: Vigil;   Drug: palcebo
Sponsor:   Bioprojet
Completed - verified January 2017


Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant)


Conditions:   Narcolepsy;   Cataplexy
Intervention:   Drug: BF2.649
Sponsor:   Bioprojet
Completed - verified January 2017


Randomized Controlled Trial to Assess Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy


Condition:   Partial Epilepsy
Interventions:   Drug: Lacosamide;   Drug: Placebo
Sponsors:   The Cleveland Clinic;   UCB Pharma
Completed - verified December 2016

Refine Your Search Advanced Search